1-4 of 4
Husheng Ding
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma

Clinical Trials & Observations
Cristina Correia, Paula A. Schneider, Haiming Dai, Ahmet Dogan, Matthew J. Maurer, Amy K. Church, Anne J. Novak, Andrew L. Feldman, Xiaosheng Wu, Husheng Ding, X. Wei Meng, James R. Cerhan, Susan L. Slager, William R. Macon, Thomas M. Habermann, Judith E. Karp, Steven D. Gore, Neil E. Kay, Diane F. Jelinek, Thomas E. Witzig, Grzegorz S. Nowakowski, Scott H. Kaufmann
Journal: Blood
Blood (2015) 125 (4): 658–667.
https://doi.org/10.1182/blood-2014-04-571786
Published: 2015
Includes: Supplemental data
Journal Articles

Cytotoxicity of farnesyltransferase inhibitors in lymphoid cells mediated by MAPK pathway inhibition and Bim up-regulation

Husheng Ding, Jennifer Hackbarth, Paula A. Schneider, Kevin L. Peterson, X. Wei Meng, Haiming Dai, Thomas E. Witzig, Scott H. Kaufmann
Journal: Blood
Blood (2011) 118 (18): 4872–4881.
https://doi.org/10.1182/blood-2011-02-334870
Published: 2011
Includes: Supplemental data
Journal Articles

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Clinical Trials & Observations
Thomas E. Witzig, Hui Tang, Ivana N. M. Micallef, Stephen M. Ansell, Brian K. Link, David J. Inwards, Luis F. Porrata, Patrick B. Johnston, Joseph P. Colgan, Svetomir N. Markovic, Grzegorz S. Nowakowski, Carrie A. Thompson, Cristine Allmer, Matthew J. Maurer, Mamta Gupta, George Weiner, Ray Hohl, Paul J. Kurtin, Husheng Ding, David Loegering, Paula Schneider, Kevin Peterson, Thomas M. Habermann, Scott H. Kaufmann
Journal: Blood
Blood (2011) 118 (18): 4882–4889.
https://doi.org/10.1182/blood-2011-02-334904
Published: 2011
Journal Articles

A Phase II Study of the Farnesyltransferase Inhibitor Tipifarnib Demonstrates Anti-Tumor Activity In Patients with Relapsed and Refractory Lymphomas

Thomas E. Witzig, MD, Tang Hui, PhD, Ivana N Micallef, MD, Stephen M. Ansell, MD, PhD, Brian Link, David James Inwards, MD, Luis Porrata, MD, Patrick B Johnston, MD, PhD, Joseph Colgan, Svetomir Markovic, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Cristine Allmer, Matthew J Maurer, George Weiner, MD, Raymond J. Hohl, MD, PhD, Paul Kurtin, MD, Husheng Ding, PhD, Loegering A David, MD, Paula A Schneider, Kevin L Peterson, Thomas M. Habermann, MD, Scott H. Kaufmann, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 287.
https://doi.org/10.1182/blood.V116.21.287.287
Published: 2010